STIM1 and breast cancer: It can be concluded from the results obtained in the present study that the combinatorial approach using sertraline, plumbagin and Orm possess effective anticancer activity in breast cancer comparable or even better than Tam which is clinically used, at the same time with lesser cytotoxicity on normal cells.